What are myeloproliferative neoplasms?
Myeloproliferative neoplasms (MPN) are a group of blood cancers that begin with an abnormal change in a stem cell in the bone marrow. This change causes the bone marrow to make too many of any one or more kinds of blood cells.
This group of blood disorders includes polycythemia vera, essential (primary) thrombocythemia and myelofibrosis.
This group of blood disorders includes polycythemia vera, essential (primary) thrombocythemia and myelofibrosis.
In Canada, it is estimated that up to 1,500 new cases of MPN are diagnosed per year.
You are not alone.
Know that the blood cancer community is here to support you every step of the way.
Experiences of others

Myeloproliferative Neoplasms News
Addressing the global Pegasys® shortage
The Leukemia & Lymphoma Society of Canada and the Canadian MPN Network have been working alongside clinicians, pharmaceutical manufacturers and Health Canada to find a solution for Canadians who are impacted by myeloproliferative neoplasms (MPN).
Resources on Myeloproliferative neoplasms
Understanding clinical trials
Get an overview of clinical trials, understand them, how they are planned, evaluate benefits and risks of participating, address concerns and what to ask.
Blood and Marrow Stem Cell Transplant
Get an overview of what your blood and bone marrow do; understand the different types of stem cell transplants; learn who is eligible for a stem cell transplant; find out how to prepare for a stem cell transplant; learn about recovery.
Types of blood cancer treatments
You or your loved one has been diagnosed with a type of blood cancer. Cancer treatment can be complex, with different types of treatment options available for some blood cancers. What are they and how do they work? This fact sheet will help you Learn about the different treatment options available, Understand each type of treatment and how it can help, Prepa…
Shared Decision Making: Discussion tool for people with a blood cancer
You or your loved one has been diagnosed with a type of blood cancer. You will be making important decisions with your healthcare team.
Myelofibrosis: A Conversation with Doug Chisolm
Ever since he was diagnosed with myelofibrosis 20 years ago, Doug Chisolm has tried to live every day to the fullest, even spending all his retirement savings and having to start saving again. In this episode, Doug speaks about the ups and downs of his blood cancer experience, why he thinks it's crucial to have a strong support system and what he shares as a…
Dr. Dawn Maze Podcast - Myeloproliferative neoplasms (MPN): Progress in treatment
In the last 10 years, there have been many advancements in the treatment of MPNs. In combination with a better overall understanding of its causes and what contributes to its progression, Dr. Dawn Maze says it is a very "exciting" time in the treatment of MPNs.
In this episode, Dr. Maze, a hematologist at Toronto's Princess Margaret Cancer Centre, explain…
Myelofibrosis (MF) therapies: From palliation to disease modification - myeloproliferative neoplasms (MPN) conference 2025
Dr. Vikas Gupta, Hematologist at the Princess Margaret Cancer Centre in Toronto, reviewed Myelofibrosis (MF) and the evolution in diagnosis, treatment options and aspects of follow-up care in this 1-hour webcast as part of MPN Conference 2025.
Understanding essential thrombocythemia (ET): Diagnosis, treatments and follow-up care: MPN conference 2025
In this 1-hour webcast, Dr. Lynda Foltz, University of British Columbia, will review this type of myeloproliferative neoplasm (MPN): its diagnosis, treatment options, and aspects of follow-up care.) People with ET have too many platelets, a type of blood cell. Too many platelets can result in a blood clot (thrombosis) forming in a blood vessel.
Understanding polycythemia vera (PV): Diagnosis, treatments and follow-up care - myeloproliferative neoplasms (MPN) conference 2025
In this 1-hour live webcast, Dr. Sonia Cerquozzi, hematologist at the Tom Baker Cancer Center and Peter Lougheed Centre in Calgary, reviews PV, a type of MPN - its diagnosis, treatment options and aspects of follow-up care.
There are four main types of MPN.
The treatment for MPN varies according to the type and stage of the disease with the goal of slowing or stopping the disease from becoming acute myeloid leukemia (AML). After treatment, many people get relief from the symptoms of MPN. You may find that knowing more about the disease and its treatment can help you cope.